Amphastar Pharmaceuticals, Inc. AMPH on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001297184
0001297184
EIN:
33-0702205
33-0702205
LEI:
(CF Office: 03 Life Sciences)
Business address:
11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
Phone: 909-980-9484
11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
Phone: 909-980-9484
Mailing address:
11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
Category:
Large accelerated filer
Large accelerated filer
Filings:
852 EDGAR filings since February 11, 2005
852 EDGAR filings since February 11, 2005
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- April 1, 2025 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 6, 2025 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 4, 2025 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 3, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- February 27, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
Selected Filings
[+] 8-K (current reports)
- February 27, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- March 3, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- November 7, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 9, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 10, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- April 12, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- March 18, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 18, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 18, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 48 of 852 entries
Data source:
CIK0001297184.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
